EPISODE · Nov 19, 2025 · 19 MIN
EP021 | Tirzepatide vs Semaglutide：NEJM 發表最新 SURMOUNT-5 研究，揭示誰是肥胖者的最佳減重武器？
from 葉峻榳醫師學習護照 · host YehG.com
https://www.yehclinic.com/tirzepatide-vs-semaglutide-nejm-surmount-5-trial/權威期刊新英格蘭醫學期刊 (May 11, 2025, at NEJM.org) 最新發表，揭示了控糖減重藥物 Tirzepatide (商品名：Mounjaro® 猛健樂, Zepbound®) 跟 Semaglutide (商品名：Ozempic® 胰妥讚, Wegovy® 週纖達) 的直球對決結果，告訴我們這兩款瘦瘦針哪一種效果比較強？
Embed this episode
Ready to play
EP021 | Tirzepatide vs Semaglutide：NEJM 發表最新 SURMOUNT-5 研究，揭示誰是肥胖者的最佳減重武器？
0:00
19:53
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 葉峻榳醫師學習護照?
This episode is 19 minutes long.
When was this 葉峻榳醫師學習護照 episode published?
This episode was published on November 19, 2025.
Can I download this 葉峻榳醫師學習護照 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!